MICHAEL BRAUN to Neoplasm Staging
This is a "connection" page, showing publications MICHAEL BRAUN has written about Neoplasm Staging.
Connection Strength
0.090
-
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol. 2022 05; 23(5):625-635.
Score: 0.034
-
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer Med. 2021 12; 10(23):8581-8594.
Score: 0.033
-
Who may benefit from preoperative breast MRI? A single-center analysis of 1102 consecutive patients with primary breast cancer. Breast Cancer Res Treat. 2015 Oct; 153(3):531-7.
Score: 0.022